Pitch Introduction
The Matri Shark Tank India pitch introduced one of the most socially impactful medical devices seen in Season 3. Founders Rony Mandal and Rohan Roy from Kolkata, West Bengal, presented their innovative product designed to tackle a problem affecting over 80% of women: menstrual pain. Dubbed the “modern version of Padman” by Anupam Mittal, the founders shared their journey of creating a drug-free, portable, and wireless solution to a biological challenge that often disrupts education and work for millions of women every month.
During their presentation, the founders explained that while conventional remedies like hot water bags and painkillers exist, they are either inconvenient for use in public or carry long-term side effects. Matri aims to bridge this gap by offering a wearable gadget that provides relief within 10 to 15 minutes. The pitch was not just about a product but about breaking taboos surrounding menstruation in India. They walked into the tank seeking ₹60 Lakhs for 4% equity, valuing their pre-revenue startup at ₹15 Crores.
Business Overview
Matri, operated under Sifam Technology, is a health-tech startup focused on feminine wellness. The core product is a miniaturized electronic device that uses advanced pulse technology to block pain signals. Unlike traditional TENS (Transcutaneous Electrical Nerve Stimulation) machines used in physiotherapy, Matri is specifically calibrated for the muscle structure of the uterus and the lower abdomen, making it a specialized tool for period cramps.
The business model is primarily D2C (Direct-to-Consumer), with plans to sell through their official website and major e-commerce platforms like Amazon. By focusing on a sleek, fashionable design, the founders have ensured that the device can be worn discreetly under clothing, allowing women to go about their daily routines in schools, colleges, or offices without the burden of pain or the bulkiness of traditional heating pads.
Product Details
The Matri device is a result of years of iteration. It consists of a compact, rechargeable controller and two self-adhesive gel pads. These pads are placed on the lower abdomen, and when switched on, the device sends a specific range of electric pulses that interfere with the pain signals traveling to the brain. This mechanism is based on the Gate Control Theory of pain management.
The device comes in two versions: a wired version and a wireless version. The wireless model is particularly designed for working women who require maximum mobility. According to the founders, the product has been tested on over 400 women, with a 96% positive feedback rate. It is designed to be safe, with the founders already securing a test license and applying for a manufacturing license from the CDSCO.
Market Position
Matri positions itself as a premium yet accessible alternative to pharmaceutical interventions. While there are international competitors, such as Israeli brands, Matri’s unique selling proposition lies in its patented pulse patterns specifically designed for menstrual anatomy and its significantly lower price point compared to global alternatives. Their strategy involves creating a brand that advocates for women’s health through influencer marketing and awareness campaigns in educational institutions.
| Business Detail | Information |
|---|---|
| Company Name | Sifam Technology (Brand: Matri) |
| Founders | Rony Mandal and Rohan Roy |
| Product Type | Medical Health / FemTech Device |
| Problem Solved | Menstrual Pain (Dysmenorrhea) |
| Primary Channel | D2C (Website, Amazon) |
| Headquarters | Kolkata, West Bengal |
About Founder’s
The journey of Rony Mandal and Rohan Roy is a classic story of entrepreneurial grit and perseverance. Both are school friends from Kolkata who shared a passion for electronics from a young age. Their motivation for Matri came from observing the struggles of their own family members—Rony’s elder sister and Rohan’s mother—who suffered from severe menstrual discomfort.
Their story of building the first prototype is particularly inspiring. Lacking initial funds, the duo manufactured LED bulbs and spent three months selling them on the streets of Kolkata to raise a capital of ₹50,000 to ₹60,000. This self-funded capital allowed them to develop their first basic prototype while they were still in college. They eventually gained incubation support from IIT, which provided them with lab access, followed by seed funding of ₹10 Lakhs after two years of research. Their dedication to the cause led Anupam Mittal to compare them to the legendary “Padman” for their efforts in the menstrual hygiene and health space.
- Rony Mandal: Co-founder with a background in electronics and IoT home automation.
- Rohan Roy: Co-founder and childhood friend, specializing in product development.
- Resourcefulness: Sold street-side LED bulbs to fund their initial medical R&D.
- Academic Support: Incubated at RCC Institute and partnered with AIIMS Patna for testing.
Shark’s and Founder’s QnA
How did you jump from general electronics to solving menstrual pain?
While noting down problems that people face every month, we realized menstrual pain was a recurring issue in our own families. My sister and Rohan’s mother struggled with it. We decided to apply our knowledge of electronics to solve this specific biological problem.
What is the science behind the Matri device?
The device works on the Gate Control Theory. Pain is essentially an electric signal traveling to the brain. We send a specific range of pulses that block these signals. Because the muscle structure of the uterus involves specific fat and tissue, we have designed unique pulse patterns specifically for this anatomy.
Does this product have any intellectual property (IP) protection?
Yes, we have a patent on the utility and the specific pattern of pulses our device generates. While TENS technology is old, our miniaturization and the specific calibration for menstrual pain are our original inventions.
Is the product clinically tested?
We have tested it on 400 plus women with a 96% positive response rate. We have a test license and have collaborated with AIIMS Patna and JIMS Hospital for ongoing clinical data collection. On a scale of 10, users have reported pain dropping from a 9 to a 2 or 3 after 15 minutes of use.
What is your go-to-market strategy?
We are launching as a D2C brand through our website and Amazon. We also plan to create awareness through gynecologist channels and conduct campaigns in schools and colleges. Influence marketing will play a huge role in breaking the taboo and reaching our target audience.
Where do you see this business in the next five years?
We see it as a ₹100 Crore business. We have more products in the pipeline, including a device to reduce labor pain and an IoT-based version, Matri 2.0, which can be controlled via a mobile app to adjust intensity settings.
Key Stats & Financials
At the time of the Matri Shark Tank India pitch, the company was in its pre-revenue/launch stage. The founders had spent nearly six years in research and development, funded by their own savings and a small seed round. Their valuation request was based on the potential of the patented technology and the massive unaddressed market for menstrual health in India.
Revenue and Profitability
- Lifetime Sales: Pre-revenue (Product ready for launch)
- Seed Funding: ₹10 Lakhs (from incubation partner)
- Entrepreneur Valuation: ₹15 Crores
- Investment Request: ₹60 Lakhs for 4% equity
- Testing Feedback: 96% positive response from 400+ test subjects
Financial Breakdown
| Metric | Amount / Value |
|---|---|
| Original Ask | ₹60 Lakhs | 4% |
| Requested Valuation | ₹15 Crores |
| Initial Capital Raised | ₹60,000 (from bulb sales) |
| Pre-Incubation Grant | Lab Access (IIT) |
| Clinical Test Sample Size | 400+ Women |
Business Potential and TAM
The business potential for Matri is immense, given the global shift towards FemTech (Female Technology). According to market research, the global FemTech market is projected to reach over $100 Billion by 2030. In India, where approximately 355 million women are of menstruating age, the market for products that provide pain relief is largely dominated by unorganized heating solutions or generic pharmaceuticals. Matri addresses a critical white space by providing a tech-enabled, recurring-use medical gadget.
The Total Addressable Market (TAM) includes every menstruating woman who experiences moderate to severe cramps. With over 80% of women reporting menstrual pain, the domestic opportunity alone is worth billions of rupees. Beyond India, the product has significant export potential, especially in Western markets where drug-free wellness solutions are highly valued. The founders’ plan to expand into labor pain relief and IoT-integrated health monitors further increases their serviceable available market.
Market Size Analysis
The Indian period care market is currently transitioning from basic hygiene (sanitary pads) to advanced wellness. While the sanitary napkin market is valued at over ₹5,000 Crores, the ancillary segment for pain management is growing at a CAGR of 15%. Matri’s goal to capture even 1% of the urban menstruating population would lead to a revenue stream exceeding ₹50 Crores annually, assuming a competitive retail price for the device.
Growth Opportunities
- Labor Pain Relief: Developing a modified TENS device for maternity hospitals to assist during childbirth.
- Subscription Model: Offering replacement gel pads and specialized wellness kits as a recurring revenue stream.
- Institutional Sales: Partnering with corporate offices and schools to provide Matri units in medical rooms.
- International Expansion: Exporting to markets like the USA and Europe where FemTech adoption is highest.
Matri: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Primary Age Group | 15 to 35 years |
| Secondary Age Group | 35 to 50 years (Perimenopause support) |
| Interests | Wellness, Tech Gadgets, Holistic Health |
| Platform Preference | Instagram, YouTube, Lifestyle Blogs |
| Geography | Tier 1 and Tier 2 Cities in India |
| Buying Behavior | Online shoppers, Wellness-conscious users |
Marketing and Distribution Strategy
Matri’s strategy revolves around building trust through clinical validation and relatability. Menstruation is often discussed in hushed tones in India, and the brand aims to normalize these conversations by positioning the device as a “switch for pain.” Their marketing approach is multi-pronged, focusing on both digital presence and professional endorsements.
Customer Acquisition
The primary customer acquisition channel is Performance Marketing on social media. By targeting users searching for period pain remedies, Matri can convert high-intent shoppers. Additionally, they plan to use influencer marketing, specifically working with female health advocates and gynecologists who can explain the science of the device to their followers. This “top-of-funnel” awareness is crucial for a new product category like electronic pain relief gadgets.
Distribution Channels
- Own D2C Website: For brand storytelling and exclusive bundles.
- E-commerce Marketplaces: Amazon and Flipkart to leverage existing logistics networks.
- Pharma Partnerships: Collaborating with companies like Emcure (Namita Thapar’s domain) for OTC availability.
- Experience Zones: Potential pop-ups in girls’ hostels and corporate parks for product trials.
Social Media and Content Strategy
Matri focuses on educational content that explains the “Gate Control Theory” in simple terms. They utilize short-form video content (Reels/Shorts) to demonstrate the portability of the device. By partnering with wellness influencers, they aim to create “viral moments” that showcase how the device fits into a modern woman’s lifestyle—from gym sessions to office meetings.
Matri Shark Tank Deal Outcome
The pitch triggered a massive bidding war among the sharks. Anupam Mittal offered ₹60 Lakhs for 10% equity, citing the high amount of work required for an early-stage startup. Ritesh Agarwal, impressed by their perseverance, made a significant offer of ₹1 Crore for 4% equity, valuing the company at ₹25 Crores.
However, the founders were looking for strategic expertise in D2C and healthcare. Namita Thapar offered ₹60 Lakhs for 6%, emphasizing her pharmaceutical background. Aman Gupta joined the offer to provide D2C and branding expertise. Ultimately, the founders negotiated a deal of ₹60 Lakhs for 4% equity with Namita and Aman, choosing strategic synergy over Ritesh’s higher valuation offer.
| Shark | Offer Detail |
|---|---|
| Namita Thapar | ₹30 Lakhs for 2% (Part of joint deal) |
| Aman Gupta | ₹30 Lakhs for 2% (Part of joint deal) |
| Ritesh Agarwal | Offered ₹1 Crore for 4% (Rejected) |
| Anupam Mittal | Offered ₹60 Lakhs for 10% (Rejected) |
| Final Decision | ₹60 Lakhs for 4% Equity (Namita & Aman) |
Matri Post-Show Update
According to The Indian Express, the founders were highly praised for their grit, especially after revealing they sold light bulbs to fund their medical research. Post-show, the founders received significant attention for rejecting a higher valuation from Ritesh Agarwal to work with Namita and Aman. Ritesh later commented on social media as reported by Times of India, stating “koi baat nahi, kingmaker bhi hona chahiye” (it’s okay, there should be a kingmaker too), showing his support for the brand despite missing the deal.
The product, Matri, gained traction as a drug-free alternative in the menstrual health space. As of 2024, the brand continues to focus on its clinical trials with AIIMS Patna and JIMS Hospital to further solidify its medical standing before a massive commercial rollout. Their focus remains on the D2C channel to maintain high margins and direct customer feedback.
Business Analysis & Lessons
The success of the Matri pitch highlights the importance of problem-solution fit and founder resilience. Rony and Rohan didn’t just build a product; they built a solution to a deeply personal and widespread pain point. By choosing a lower valuation deal from Sharks with specific domain expertise (Pharma and D2C electronics), they demonstrated long-term strategic thinking over short-term financial gain. Their ability to miniaturize a complex medical technology into a wearable consumer gadget is a testament to their technical skill and market understanding.
For entrepreneurs, Matri offers a masterclass in bootstrapping. The fact that they funded their initial research by selling consumer goods on the street resonated deeply with the Sharks. This “jugaad” approach, combined with institutional support from IITs and hospitals, creates a powerful narrative that investors find hard to resist. The pitch also underscores that in medical technology, clinical validation and IP protection are the primary drivers of valuation, even in the pre-revenue stage.
Key Takeaways
- Strategic Alignment: Choosing investors based on their industry network (Pharma/Electronics) can be more valuable than a higher valuation.
- Resourcefulness: Initial funding doesn’t always require an external investor; selling small products to fund R&D is a viable bootstrapping path.
- Niche Calibration: Adapting a general technology (TENS) for a specific medical condition (menstrual pain) creates a strong USP.
- Taboo-Breaking Marketing: Solving a problem that people are hesitant to discuss can lead to viral growth if the marketing is empathetic and educational.
Pitch Conclusion
The Matri Shark Tank India pitch stands out as a beacon of innovation in the Indian FemTech space. Rony Mandal and Rohan Roy proved that with enough determination and technical expertise, even complex medical problems can be addressed through accessible technology. By securing a deal with Namita Thapar and Aman Gupta, Matri is well-positioned to become a household name in women’s health across India.
If you enjoyed this breakdown, check out MeduLance, Neuphony, and WeHear.
[faq_accordian]